Cited by 136Mobile Health and mHealth ApplicationsChronic Obstructive Pulmonary Disease (COPD) ResearchMedication Adherence and Compliance

Digital technologies and adherence in respiratory diseases: the road ahead

Open access
Blakey, John D., Bender, Bruce G., Dima, Alexandra L., Weinman, John, Safioti, Guilherme, Costello, Richard W.·2018·European Respiratory Journal

Abstract

Outcomes for patients with chronic respiratory diseases remain poor despite the development of novel therapies. In part, this reflects the fact that adherence to therapy is low and clinicians lack accurate methods to assess this issue. Digital technologies hold promise to overcome these barriers to care. For example, algorithmic analysis of large amounts of information collected on health status and treatment use, along with other disease relevant information such as environmental data, can be used to help guide personalised interventions that may have a positive health impact, such as establishing habitual and correct inhaler use. Novel approaches to data analysis also offer the possibility of statistical algorithms that are better able to predict exacerbations, thereby creating opportunities for preventive interventions that may adapt therapy as disease activity changes. To realise these possibilities, digital approaches to disease management should be supported by strong evidence, have a solid infrastructure, be designed collaboratively as clinically effective and cost-effective systems, and reflect the needs of patients and healthcare providers. Regulatory standards for digital interventions and strategies to handle the large amounts of data generated are also needed. This review highlights the opportunities provided by digital technologies for managing patients with respiratory diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/13993003.01147-2018

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • User adherence is crucial to the effectiveness of DHT applications in the real world, which can be affected by convenience, user experience, and true benefits brought by this technology.

    “User adherence is crucial to the effectiveness of DHT applications in the real world, which can be affected by convenience, user experience, and true benefits brought by this technology (for example, helping them decide when to contact their provider, being more aware of their symptoms, and feeling more connected to their provider).138,139”

    From Artificial intelligence in diabetes management: Advancements, opportunities, and challenges (2023) · cites this paper as [138]

    In ‘Considering the intended users of the interventions’ (page unavailable), the paper says sustained real-world use is critical to digital technologies’ success and discusses user experience, desirable features, and reasons patients disengage. It does not specifically identify convenience as a factor or substantiate the cited sentence’s examples of deciding when to contact a provider, becoming more aware of symptoms, or feeling more connected to a provider. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 97 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Blakey, J. D., Bender, B. G., Dima, A. L., Weinman, J., Safioti, G., & Costello, R. W.
Affiliations
  • University of Liverpool (GB)
  • National Jewish Health (US)
  • Lyon 1 Université (FR)
  • King's College London (GB)
  • Teva Pharmaceuticals (Netherlands) (NL)
  • Royal College of Surgeons in Ireland (IE)
Venue
European Respiratory Journal
Published
2018-11
Volume
52
Issue
5
Pages
1801147
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2899639745
Cited by
136
References
97
Citations by year
2026: 4 · 2025: 19 · 2024: 25 · 2023: 22 · 2022: 14 · 2021: 22 · 2020: 19 · 2019: 10 · 2018: 1
FWCI
2.37
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • European Respiratory Journal (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Royal College of Surgeons in Ireland (submittedVersion, cc-by-nc-sa)
  • Figshare (submittedVersion, cc-by-nc-sa)
  • Research Portal (King's College London) (submittedVersion)
Funders
Teva Pharmaceutical Industries
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Keywords
digital health technologies, medication adherence, chronic respiratory disease, inhaler technique, exacerbation prediction, personalized interventions, disease management, environmental data, regulatory standards, data privacy, cost-effectiveness
MeSH terms
Asthma, Chronic Disease, Humans, Respiratory Tract Diseases, Self Care, Telemetry, Telemedicine, Pulmonary Disease, Chronic Obstructive, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review